GLUCONORM VG 1 PLUS

GLUCONORM VG 1 PLUS TAB is an innovative formulation designed for adults managing Type 2 Diabetes Mellitus, particularly useful when dietary changes, exercise, or multiple treatments do not suffice, or when more stringent management of post-meal glucose levels is necessary. This medication utilizes a synergistic blend of three complementary mechanisms to achieve substantial reductions in both fasting and post-meal blood sugar. The components of this tablet work collectively to boost insulin release, enhance the sensitivity of tissues to insulin, decrease glucose production by the liver, and slow down the process of carbohydrate digestion and absorption. By maintaining tighter control over blood glucose levels, GLUCONORM VG 1 PLUS TAB is instrumental in staving off the advancement of diabetes and its severe complications, such as kidney damage, visual impairment (retinopathy), nerve damage (neuropathy), foot issues, and cardiovascular conditions (such as heart attacks and strokes). This multifaceted approach contributes to a healthier lifestyle. The formulation combines Glimepiride, Metformin, and Voglibose in optimal doses, ensuring a robust strategy for effective glucose management. Glimepiride enhances insulin output from the pancreas, Metformin reduces glucose synthesis from the liver while promoting insulin sensitivity in peripheral tissues, and Voglibose diminishes post-meal blood sugar spikes by hindering carbohydrate absorption in the intestines. Collectively, these actions allow for a level of glycemic control that can help prevent chronic complications and improve overall health outcomes in patients with diabetes.